Kevin MD links to an article about a new policy at Stanford:
Stanford University Medical Center will prohibit its physicians from accepting even small gifts like pens and mugs from pharmaceutical sales representatives under a new policy intended to limit industry influence on patient care and doctor education.
The policy would also apply to sales representatives from makers of medical devices and other companies, not just pharmaceutical companies. Company representatives would be barred from areas where patient treatment and doctor education occur, with some exceptions.
“We want to secure the public trust to value what happens in academic medicine,” Dr. Philip A. Pizzo, dean of the Stanford School of Medicine, said in an interview.
Stanford academic physicians will continue to be able to accept speaking fees (which can be up to $5000) for drug company dinners and CME seminars, but the residents won't get $1 pens. This really restores my trust in the Stanford University Medical Center Physicians.
1 comment:
Eli Lilly 3Q 10% profit rise is nearly all from psyche drugs including zyprexa.
How have they schemed to squeeze more money from their zyprexa cash cow when pill production has actually gone down?
ANS-Eli Lilly profiteers have jacked up the price of zyprexa to the federal govt,from the Medicare D payouts.
Eli Lilly is a big drug company that puts profits over patients.
They covered up findings that their Zyprexa has a TEN times greater risk of causing type 2 diabetes
Only 9% of Americans trust big pharma,right around the same rating as tobacco companies.
Daniel Haszard Eli Lilly zyprexa drug caused my diabetes www.zyprexa-victims.com
Post a Comment